. Differential P1-purinergic modulation of human Schlemm's canal inner-wall cells.
INTRAOCULAR PRESSURE depends directly on the rate of inflow and the resistance to outflow of aqueous humor. The ciliary epithelium secretes aqueous humor, transferring solute and water from the stroma of the ciliary process into the posterior chamber. Fluid then flows between the lens and iris into the anterior chamber. In the primate eye, fluid returns to the vasculature largely through anatomically complex structures just peripheral to the inner corneal surface, comprising the trabecular meshwork (TM) in series with Schlemm's canal (SC) and collector channels (CC) (Fig. 1A) (32) . Increased resistance to aqueous humor outflow through this system raises intraocular pressure and causes glaucoma, a major cause of irreversible blindness worldwide (46) . The diverse cellular constituents, the intricate microscopic anatomy and the marked species variability, even among mammals, all hamper progress in understanding the cellular physiology of this region of the eye.
Resistance to aqueous humor outflow is likely regulated in vivo, but the sensory and target cells of this regulation are poorly understood (14, 32) . Cells in the outflow pathway likely play a role in regulating outflow resistance because maneuvers that swell cells in this pathway increase resistance, and those that shrink cells reduce resistance in human, nonhuman primate, and calf eyes (1, 21, 48) . The site of the cell-mediated regulation is unknown, but one likely potential site of outflow regulation is the cells of the inner wall of SC, which, together with their tight intercellular junctions, form an anatomically continuous barrier to flow. Fluid may cross through pores within and/or between these cells (14, 32) and through the unusually leaky "tight junctions" linking the cells (47) . The structure and dynamics of tight junctions are regulated by a broad range of signaling cascades (8, 57) . Mechanical stress can also modulate junctional permeability because increasing the intraocular pressure reduces the number of tight junctional strands between SC cells of perfusion-fixed human eyes (59) . Whether stresses induced by volume changes of inner-wall SC cells modulate the tight junctions is unknown.
We have tried to identify the site of cell regulation of outflow resistance by taking advantage of the known effects of adenosine agonists on outflow and intraocular pressure. Adenosine (P1 purinergic) receptors (ARs) are likely important in modulating pressure, both physiologically (5) and pathophysiologically (49) (see DISCUSSION) . A 1 and A 2A AR agonists lower and raise intraocular pressure, respectively, in rabbits (9, 10), mice (3, 4) and monkeys (54) . The ocular hypotensive effect has been ascribed in monkeys entirely to outflow alteration (54) . The ocular hypertensive effect of A 2A AR agonists is also likely mediated by altered outflow because it cannot be ascribed to other potential mechanisms, such as increased inflow (54) or breakdown of the blood-aqueous barrier, at least at low doses of agonist (11, 54) .
The primary aim of the present work was to test whether selective A 1 and A 2A AR agonists exert opposing effects on human inner-wall SC cells in vitro, corresponding to their opposing effects on intraocular pressure in vivo. For this purpose, we developed a new enzyme-assisted technique to isolate and grow human inner-wall SC cells for study at an early passage number. The current study also examined the responses of SC cells to selective stimulation of A 3 ARs, receptors thought to regulate aqueous humor secretion (see DISCUSSION) . In addition, we tested whether the fourth known AR, A 2B AR, is functionally present in inner-wall SC cells.
METHODS

Enzyme-Assisted Technique for Preparing Human Inner-Wall SC Cells
To isolate and culture inner-wall SC cells, we adapted a method used for isolating and culturing microvascular endothelial cells (26) , modified to accommodate the tissue complexity of SC and the limited number of cells provided per donor eye (Fig. 1A) . We also exploited the observation that SC cells, unlike TM cells, express the marker CD31 (platelet endothelial cell adhesion molecule-1; PECAM-1) (Fig.  1B) (24, 55) . We isolated SC cells from both nonglaucomatous donor eyes stored in moist chambers and corneoscleral buttons stored in solution (Optisol-GS, Bausch and Lomb Surgical, Irvine, CA) at 4°C provided by the Lions Eye Bank of Delaware Valley (Philadelphia, PA) within 48 and 96 h after death, respectively. Fibroblasts may potentially migrate into the tissue during prolonged periods of storage; these and other potential contaminants were excluded from the final cell harvest and culture by the selective isolation procedure described below.
Corneal buttons, either dissected from whole eyes or received as such, were placed endothelial side up and divided into quarters. With the use of a scalpel blade (no. 10), the corneal endothelium and underlying Descemet's membrane with Schwalbe's line and some anterior TM were gently peeled away. The scleral spur was incised radially using a sapphire knife and stripped along its course with forceps together with all uveal TM and a major portion of the corneoscleral TM. Parallel incisions on either side of SC were made to permit lifting the inner-wall-containing tissue intact from the remaining corneoscleral tissue. The preparation thus contained some corneoscleral TM, the juxtacanalicular tissue and inner-wall SC. It was transferred to a petri dish and incubated in Ca 2ϩ -and Mg 2ϩ -free physiological buffered saline (PBS; Invitrogen, Carlsbad, CA) containing 1.0 mg/ml collagenase IV (232 U/mg protein; Worthington Biochemicals, Lakewood, NJ, IUB 3.4.24.3), 0.2 mg/ml elastase (Worthington, 3.94 U/mg protein, IUB 3.4.21.36), 0.2 mg/ml hyaluronidase (Worthington, 499 U/mg dry wt, IUB 3.2.1.35), 0.05 mg/ml DNase type 1 (2,000 U/mg protein, Roche Diagnostics, Indianapolis, IN, E.C.3.1.21.1) and 1.0 mg/ml bovine serum albumin (Sigma, St. Louis, MO). Over the next 60 -90 min, cells dissociated into single cells and/or into clumps. Depending on the degree of cell clumping, a further 5 min in 0.25% trypsin solution (Invitrogen) with 1.0 mg/ml DNase was optionally applied. A: principal outflow pathway of human aqueous humor. Fluid leaves the eye sequentially through the trabecular meshwork (TM), SC, and collector channels (CC). In addition to a cribiform or juxtacanalicular tissue region, the TM comprises uveal (UTM) and corneoscleral (CSTM) regions extending from the ciliary muscle (CM) and scleral spur (SS) posteriorly to Schwalbe's line (SL) delimiting the corneal endothelium (CE) anteriorly. B-D: light micrographs of fixed and stained sagittal cryosections through the angle of a human anterior chamber. B: as indicated by the stain, platelet endothelial cell adhesion molecule-1 (PECAM-1)/CD31 is immunolocalized specificially to SC endothelial cells within the human aqueous humor outflow region. C: the position of a gelatin-coated 6-0 nylon monofilament suture used as a matrix for proliferation of cannula-derived SC cells (52) is indicated by the asterisk. D: new method for inner-wall SC cell isolation entails removal of most TM tissue, preserving a thin SC inner-wall cell membrane (arrow). Note that most of the tissue overlying SC before the dissection step (Fig. 1C) had been removed in D. B and D appear different because of the background nuclear stain in B and the difference in magnification indicated by the bars. E: phase-contrast photomicrograph of individual endothelial inner-wall SC cells recognized by, and decorated with, a cell-specific antibody precoated with immunomagnetic beads. Inner-wall SC cells were purified by antibody to the endothelialcell specific PECAM-1/CD31 antigen. F: phase-contrast microscopy of cultured human inner-wall SC cells isolated by antibody to PECAM-1/CD31. A confluent monolayer at passage 2 displayed convex polygonal cells with close cell-to-cell apposition for the most part. Elongated and spindle-shaped cells at preconfluent state can also be noted.
After detachment, cells were twice suspended in F99 medium, supplemented with 10% certified fetal bovine serum (FBS), 2.5 g/ml amphotericin B and 50 g/ml gentamicin, and centrifuged. Cells were incubated in four gelatin-coated four-well cell culture multidishes (1.9 cm 2 area per well, Nalgene Nunc, Rochester, NY) with supplemented F99 medium as described above plus 20 ng/ml human recombinant basic fibroblastic growth factor (Roche Diagnostics) and 10 ng/ml human recombinant epidermal growth factor (Roche Diagnostics) to induce proliferation. Media were changed after 24 h for the first time and thereafter three times a week without subsequent growth factor supplementation.
After growth to confluence, cells were trypsinized (0.25%) until suspensions of single cells were obtained. A cell strainer (Falcon, 40 m) was used if cell clumping was still observable before the cells were seeded onto antibody-coated wells. The wells were prepared by coating cell culture 4-well plates with the SC-cell specific CD31 antibody (Fig. 1E) (24, 55) , following the approach of Matteson and Deutsch (39) . Plates were incubated with mouse anti-human CD31 antibody (DAKO Cytomation, Carpinteria, CA) diluted 1:20 (22.5 g/ml) in a 0.2 M TRIZMA-HCl buffer (pH 9.5; Sigma) for 1 h at 4°C. The wells were rinsed three times with cold PBS containing 1% FBS before the cells were seeded. After being seeded, the cells were incubated for Ͼ2 h at 4°C. Nonadherent cells were carefully rinsed off three times with cold PBS containing 1% FBS. After nonadherent cells were removed, culture medium containing 20 g/ml bovine fibronectin (Invitrogen) was added once, and the SC cells were grown after separation with the antibody (passage 1) (Fig. 1F) . Upon reaching confluence, the cells were used for experiments and/or split for passage 2. All measurements were conducted at passages 1-3.
Cannula-Derived Mixed Human Inner-and Outer-Wall SC Cells
For purposes of comparison, we also isolated and grew SC cells by an established cannula-derived technique (52) . A gelatin-coated suture serving as growth substrate was inserted into the intact SC. After 3 wk, cells were transferred from the suture to 6-well culture plates containing Dulbecco's modified Eagle's medium supplemented with 10% FBS, 100 U/ml penicillin G sodium, and 100 g/ml streptomycin sulfate, incubated at 37°C in humidified air with 7% CO 2 and further passaged at the split ratio 1:4 in T25 culture flasks. Cell strains used in this study were from three different donors (SC3, SC20, and SC26) and studied at passages 2 and 3.
SC cells cultured by the cannula-derived method were distinguished from cultures of fibroblasts by morphology and growth characteristics. Cultures of TM cells grew in a monolayer and had broad, flat cell bodies with many processes, whereas cultures of fibroblasts grew in multiple layers, were thin and elongated, and displayed thin multidigited processes. Cultures of SC cells were also distinguished from cultures of TM cells by absence of induction of myocilin after dexamethasone treatment and generation of transendothelial electrical resistance of Ն10 ⍀ cm 2 after 1 wk at confluence (52) . Given the initial propagation strategy, the cultures of SC cells were likely derived from both inner and outer walls of SC and may have undergone many divisions during the 3-wk incubation period and subsequent passages necessary to obtain adequate numbers of cells.
Intracellular Ca 2ϩ Levels
Intracellular Ca 2ϩ concentration was measured in individual cells or in confluent monolayers as previously described (41) . Individual cells were seeded on coverslips (Fisher Scientific, Pittsburgh, PA) and allowed to attach for 60 -90 min before being loaded with dye or grown for 1-11 days to prepare confluent monolayers, and were loaded in the dark with 5 M fura-2 AM and 0.01% Pluronic F-127 (Molecular Probes, Eugene, OR) for 30 -71 min at 25°C.
For study of individual cells, coverslips were mounted in an inverted Nikon Diaphot microscope, visualized with a ϫ40 oilimmersion fluorescence objective and perfused with fura-free solution for 21-38 min (Table 1) . Fields of individual cells were chosen to include 1-6 nonconfluent cells of comparable diameter and dye loading. Data were acquired with an IC-200 charge-coupled device (CCD) camera at an emitted fluorescence of 520 nm after excitation at 340 and 380 nm. Fluorescent images of the cells were captured every 5 s using the IC-200 CCD camera, sent to the computer, and saved. Imagemaster software (Photon Technology International) was used to analyze the images and extract the emission signal from individual cells. Data were then copied to the Felix software program (Photon Technology International), where the ratio was determined and Ca 2ϩ concentration calculated (41) .
Confluent monolayers were sampled at 1 Hz using a photomultiplier tube, using the same excitation and emission wavelengths. The ratio was determined and the data analyzed using Felix software (Photon Technology International).
Patch Clamping
Cells were trypsinized, resuspended, and permitted to settle on glass coverslips. Whole cell patch-clamp currents were recorded in the ruptured-patch mode using an Axopatch 1B or 1D patch-clamp amplifier (Axon Instruments, Foster City, CA) connected to an external 8-pole Bessel filter (model 990C, Frequency Devices, Haverhill, MA). Micropipettes were pulled from Corning no. 7052 glass (World Precision Instruments, Sarasota, FL) with a Flaming/Brown micropipette puller (model P-97, Sutter Instruments, Novato, CA), coated with Sylgard (World Precision Instruments) and fire polished with a microforge (model MF-830, Narishige). Micropipettes displayed resistances of 2-4 M⍀ when filled with micropipette solution (Table 1) and several gigohms after forming successful seals. Potential was measured in a perfusion chamber connected to an Ag/AgCl pellet in 3 M KCl solution via a 3 M KCl agar bridge.
The potential was stepped for 30 ms from a holding potential of Ϫ80 mV to test values from Ϫ100 to ϩ80 mV in 20-mV increments at 2-s intervals. Applied voltages were not corrected for the small junction potential (about Ϫ2.8 mV; Ref. 7) arising from the present micropipette filling and external solution (Table 1) . Data were acquired at 2-5 kHz and filtered at 500 Hz using an Axon Digidata interface coupled with pCLAMP version 8.2 software. The results were analyzed with Clampfit 8.2 software (all from Axon Instruments). Current activations were quantified at the peak responses and current inhibitions at the smallest values following the perturbation; where possible, 2-3 points were averaged to estimate baseline and perturbed values. In analyzing data from multiple experiments, we have followed our standard practice of averaging currents measured at ϩ80 mV because the values were largest at that test potential.
Drugs and Experimental Solutions
Unless otherwise stated, all drugs were purchased from Sigma. The AR agonists and antagonists used are presented in Table 2 . Of these purinergic drugs, the A 2A antagonist 4-{2-[7-amino-2-(2-furyl)(1,2,4)triazolo(2,3-a)(1,3,5)triazin-5-ylamino]ethyl}phenol (ZM-241385) was obtained from Tocris (Ballwin, MO).
The Cl Ϫ -channel and K ϩ -channel blockers used were 5-nitro-2-(3-phenylpropylamino)-benzoate (NPPB) (56) and tetraethylammonium (TEA), respectively. Compositions of solutions for patch clamping are entered in Table 1 .
Data Analysis
Means Ϯ SE were calculated from analysis of n experiments. The SE rather than SD was chosen as the index of uncertainty because we are focusing on the significance of averaged responses and not on the uncertainty associated with a single measurement. Uncertainties are entered as ϮSE for n Ն 3, and as half the difference between replicate measurements for n ϭ 2. The probability (P) of the null hypothesis was estimated with Student's paired t-test applied to results satisfying normality. Where normality was not met by the raw data, exponentially transformed data did conform to normality. Results were considered significant if P was Ͻ0.05.
RESULTS
Inner-Wall SC Cells: Whole Cell Currents
Baseline properties. Confluent cultures of cells derived from SC inner wall were largely polygonal with close cell-to-cell apposition. Subconfluent cultures in passage 1 displayed a range of morphologies, for the most part elongated to spindle shaped; this was especially true of cells in migration or establishing contact with one another (Fig. 1F) . A similar range of morphologies has been reported for various endothelial cells in culture (25, 51) . Inner-wall SC cells at around passage 4 also tended to start displaying increased cell size and change in shape to a more elongated morphology, as observed in the cannula-derived cultures. The latter SC cells were fusiform, forming nonoverlapping linearly oriented monolayers, as previously reported (52) .
We patch clamped round cells (21.8 Ϯ 0.8 m in diameter, measured in 51 cells). TEA (7.5 mM) inhibited inner-wall SC currents by 57 Ϯ 4% from baseline values of 984 Ϯ 319 pA (39 pA/pF, n ϭ 28, P Ͻ 0.001) at ϩ80 mV. This indicated that K ϩ channels contributed much of the baseline membrane conductance, as found with TM cells (17, 53) .
Selective agonists of A 1 , A 2A , and A 3 ARs. We tested whether the baseline currents were differentially affected by subtypeselective adenosine receptor agonists. The A 1 AR agonists S-ENBA and N 6 -cyclopentyladenosine (CPA) both activated whole cell currents (Figs. 2 and 3, Table 3 ). At 100 nM, S-ENBA increased currents by 587 Ϯ 199% (n ϭ 22, P Ͻ 0.001). Details concerning the fraction of applications and cells that responded significantly to this and other agonists and the statistical test used for each data set are provided in Table 3 . Unless otherwise indicated, the entries in Table 3 are means Ϯ SE averaged for all agonist and antagonist applications. The S-ENBA-activated difference currents displayed delayed outward rectification (Fig. 2, B and C) and were inhibited by 7.5 mM TEA by 53 Ϯ 7% (n ϭ 6, P ϭ 0.002, Fig. 2A) , comparable to the effect of TEA on baseline currents cited above. As illustrated by Fig. 2A , the magnitude of the S-ENBA-triggered activation was variable, even in repetitive applications to the same cell. In that figure, the initial response was small and transient, whereas the two subsequent responses were more sustained and an order of magnitude larger. CPA also activated whole cell currents, albeit less consistently. The frequencies and magnitudes of CPA-triggered activations at concentrations of 15, 50, and 100 nM are presented in Fig. 3 . In contrast to subtype-selective A 1 AR agonists, the A 2A AR agonist CGS-21680 (30 nM) blocked whole cell currents by 17 Ϯ 7% (n ϭ 7, P ϭ 0.03) (Figs. 3 and 4, Table 3 ). The A 3 AR agonist 2-chloro-N 6 -(3-iodobenzyl)-9[5-(methylcarbamoyl)-␤-D-ribofurosanyl]adenosine (Cl-IB-MECA) produced inconsistent effects at 30 and 100 nM (Fig. 3) , most commonly producing small reductions in current at 100 nM but also stimulating whole cell currents by ϳ400% in 2/8 applications.
NECA-based stimulation of A 2A and A 2B ARs. The magnitude of the response to the selective A 2A AR agonist was much smaller than that to the selective A 1 agonists. We also probed for the putative A 2A ARs by a different strategy. We applied a high enough concentration (10 M) of the nonselective, nonmetabolizable AR agonist NECA to stimulate all four known ARs, but in the presence of selective antagonists to A 1 (20 nM DPCPX), A 2B (100 nM MRS-1754; Refs. 31, 36), and A 3 ARs (100 nM MRS-1191). We first perfused the cells with the antagonists. During the initial period, most cells displayed either little change or only transient increases or decreases in whole cell currents. After a steady-state response was attained, Fig. 2 . Effects of the A1 adenosine receptor (A1 AR) agonist (2S)-N 6 -(2-endo-norbornyl) adenosine (S-ENBA) on whole cell currents of an inner-wall (IW) SC cell. A: S-ENBA (100 nM) produced an initial small and subsequent very large increases in whole cell currents of a single IW SC cell. Most of the increase in current was reversibly inhibited by the K ϩ channel blocker tetraethylammonium (TEA; 7.5 mM). Error bars are included within the symbols. B: S-ENBA difference currents calculated over the 20 -30 ms after step changes in potential as a function of voltage and time. C: current-voltage relationships for the S-ENBA-difference currents measured after the first, second, and third applications of the agonists, respectively. Fig. 3 . Effects of subtype-selective AR agonists on whole cell currents of IW SC cells. The heights of the bars above and below the x-axis display the means Ϯ SE of current activations and inhibitions, respectively. The numbers adjacent to the x-axis represent the numbers of activations and inhibitions, with the total number of applications of each agonist presented at the bottom. The potencies of the agonists are provided in Table 2 . CPA, N 6 -cyclopentyladenosine; Cl-IB-MECA, 2-chloro-N 6 -(3-iodobenzyl)-9[5-(methylcarbamoyl)-␤-usually after 5 min, 10 M NECA was added to the same perfusate to stimulate A 2A ARs (Fig. 5B ). With this approach, activation of A 2A ARs inhibited whole cell currents by 17 Ϯ 4% (n ϭ 11, P ϭ 0.001, Table 3 ), the same percentage inhibition produced by directly applying the A 2A AR-selective agonist CGS-21680. We used the same NECA-based strategy to probe for A 2B AR function because selective A 2B AR agonists are unavailable. We first perfused cells with antagonists to A 1 (20 nM DPCPX), A 2A (10 nM ZM-241385), and A 3 ARs (100 nM MRS 1191) until a steady state was reached. At that point, NECA was added (Fig. 5A, Table 3 ). Under these conditions and excluding an uniquely large increase of 1,376%, NECA activated whole cell currents by 50 Ϯ 16% (n ϭ 25, P Ͻ 0.001).
Summary of AR agonist and antagonist effects on innerwall SC currents.
The results obtained with subtype-selective AR agonists and antagonists indicated that stimulation of A 1 and A 2B ARs significantly increased, whereas A 2A AR stimulation significantly decreased, inner-wall SC whole cell currents (Figs. 3 and 5, Table 3 ). A 3 AR agonists exerted inconsistent effects. Given these results with subtype-selective drugs, it was not surprising that application of the physiological, nonselective agonist adenosine produced a wide range of responses at a concentration of 10 M, which stimulates all four known adenosine receptors. Adenosine increased whole cell currents in 13 applications (by 297 Ϯ 196%), decreased currents in 13 applications (33 Ϯ 5%) and exerted biphasic effects in 4 of 30 applications to 16 cells. The overall mean response to adenosine was an increase of 132 Ϯ 100% (P ϭ 0.3).
Cannula-Derived SC Cells: Whole Cell Currents
For purposes of comparison, the electrophysiological effects of subtype-selective AR agonists were also measured in a smaller series of cannula-derived SC cells, likely arising from both inner and outer wall. On average, these cells were larger Values are means Ϯ SE. AR, adenosine receptor. The probability (P) of the null hypothesis was calculated by applying Student's t-test to data sets which satisfied normality; A, normality satisfied by the untransformed data; B, normality satisfied upon exponential transformation. For CGS-21860 (100 nM) applied to the mixed SC cells, all 5 cells displayed an inhibitory response; 2/5 responses were purely inhibitory and 3/5 biphasic. The stimulation noted in 3/5 applications appeared either before (n ϭ 1) or after (n ϭ 2) the inhibition. The mean calculated by averaging the net stimulation ϩ inhibition for each cell was insignificant. Separate analysis of the stimulatory and inhibitory responses indicated that CGS-21680 produced a significant decrease. Fig. 4 . Effects of the A2A AR agonist CGS-21680 on whole cell currents of an IW SC cell. The A2A AR agonist produced slight decreases in IW SC whole cell currents reversibly and repetitively. The baseline currents were reversibly inhibited by 7.5 mM TEA.
(34 Ϯ 4 m in diameter) than the inner-wall SC cells at the time point studied. As with inner-wall SC cells, 7.5 mM TEA inhibited baseline whole cell currents (by 40 Ϯ 7%, n ϭ 7, P ϭ 0.002).
As in the case of the purely inner-wall SC cells, selective A 1 and A 2A AR agonists exerted different effects on whole cell currents of cannula-derived SC cells. Although the magnitude of the effect was smaller (13 Ϯ 2%, n ϭ 4, P ϭ 0.01, Table 3 , Fig. 6 ), the A 1 AR agonist CPA (100 nM) also increased whole cell currents. In contrast, the A 2A AR agonist CGS-21680 (100 nM) initially appeared to have no significant effect, reducing currents by 8 Ϯ 6% (n ϭ 5, P ϭ 0.1, Table 3 ). However, we noted that the A 2A AR agonist solely inhibited currents in two cells, and produced a biphasic response (both inhibition and stimulation) in three others. When the inhibitions and stimulations were averaged separately (Table 3) , the A 2A AR agonist inhibited currents by 17 Ϯ 3% (n ϭ 5, P ϭ 0.002) and produced an insignificant stimulation (P Ͼ 0.05). Therefore, the CGS-21680 seemed to produce two different effects on the cannula-derived cells, a significant decrease and a less consistent stimulation. The A 3 AR agonist Cl-IB-MECA (100 nM) produced mixed responses leading to an overall decrease of 10 Ϯ 5% (n ϭ 6, P ϭ 0.07). The frequency distributions and magnitudes of the responses are summarized in Fig. 6 and Table 3 .
Thus although the responses of the cannula-derived SC cells to subtype-selective AR agonists (Fig. 6) were qualitatively similar to those of inner-wall SC cells (Fig. 3) , several notable differences were observed. In addition to the smaller A 1 -triggered stimulation and biphasic A 2A -triggered responses (Table 3) , the responses to the nonselective agonist adenosine (10 M) were more consistently inhibitions. The overall effect was a mean inhibition of 36 Ϯ 3% (n ϭ 16, P Ͻ 0.001). Adenosine activated currents in 1, inhibited currents in 10, exerted biphasic effects in 4, and had no effect in 1 of 16 applications to 10 cells. , and 100 nM MRS-1191 against A3 ARs. The first NECA application produced a large stimulation of current, which was inhibited by TEA. The second NECA application produced another, albeit smaller, current activation. B: activation of A2A ARs with the same strategy produced a reduction of baseline currents, after which only a small further reduction was elicited by TEA. NECA (10 M) was applied during the experimental period indicated in the presence of antagonists to the other three AR receptors: 20 nM DPCPX against A1, 100 nM MRS-1754 against A2B, and 100 nM MRS-1191 against A3 ARs.
Effects of AR agonists on Intracellular Ca 2ϩ of SC Cells
AR agonists can trigger changes in intracellular Ca 2ϩ concentration in addition to the more commonly addressed alterations in cAMP levels (19, 35, 36, 42) . We measured the AR-agonist effects on SC-cell Ca 2ϩ to examine whether the differential effects on whole cell currents might be mediated by differential effects on Ca 2ϩ . The nonselective agonist adenosine elicited concentration-dependent increases in intracellular Ca 2ϩ of SC cells, as illustrated in Fig. 7A by the responses, first to 3 M, and then to 10 M adenosine. However, 100 M adenosine subsequently produced a smaller stimulation, possibly because of AR desensitization. ATP (10 M) later triggered a larger response, suggesting that the small response to 100 M adenosine had not been limited by intracellular Ca 2ϩ depletion.
The effects of AR agonists on inner-wall SC cells derived by enzymatically assisted isolation and cannula-derived SC cells are presented in the lefthand and righthand columns, respectively, of Fig. 7 . The inner-wall SC cells were studied as individual cells with a CCD camera because of the difficulty in obtaining large numbers of confluent sheets of these cells without further passaging. The cannula-derived cells were studied in confluent monolayers with a photomultiplier tube; study of the cells as confluent sheets provided a more favorable signal-to-noise ratio. The baseline Ca 2ϩ levels were 69 Ϯ 8 nM (n ϭ 21) and 169 Ϯ 33 nM (n ϭ 19) for the inner-wall SC cells and cannula-derived SC cells, respectively. For purposes of comparison, baseline Ca 2ϩ concentrations of TM cells have been found to be 136 Ϯ 15 nM (17) and 106 Ϯ 0.5 nM (27) . The responses to subtype-selective AR agonists were qualitatively similar for the two preparations of SC cells. A 1 , A 2A , and A 3 AR agonists all increased the intracellular Ca 2ϩ concentrations of the cannula-derived and inner-wall SC cells. Further details are provided in the legend to Fig. 7 .
DISCUSSION
The salient findings of the present work were the following: 1) populations of purely inner-wall SC cells could be isolated and cultured after an enzymatic treatment of human SC, and 2) A 1 and A 2A AR agonists exert differential effects on the inner-wall SC cells.
Isolation and Culture of Inner-Wall SC Cells
The new technique for isolating and growing inner-wall SC cells was adapted from a technique for culturing microvascular endothelial cells (26) . Following the preliminary dissection and enzymatic incubation, we separated inner-wall SC cells selectively from the harvested mixed-cell population with antibody to CD31 (PECAM-1), a highly reliable marker of cells of endothelial origin (2, 43, 50) expressed in human SC, but not in TM or other cells within the outflow region (24, 55) . The inner, rather than outer, wall of SC may be a/the major site of outflow regulation (14, 32) . The inner wall differs from the outer wall in several respects. First, it is usually flatter (14) with different-shaped cells about twice as small in surface size (38) . Second, there are no areas of desmin-positive cells, in contrast to the outer wall (23) . Third, reactivity to Factor VIII-related antigen is very weak, whereas the reactivity of outer-wall SC is similar to that of the collector channels and aqueous veins (22) . Fourth, the inner wall of adult human and monkey SC rarely displays Weibel-Palade bodies, which can, however, be consistently found in sections of outer-wall SC (22) . The latter two observations (3-4) have been interpreted to suggest that the inner wall retains a less vascular character than the outer wall (22) . To the best of our knowledge, the present study reports the first isolation and study of SC cells selectively from the inner wall.
Differential Effects of Subtype-Selective AR Agonists on Inner-wall SC Cells
The electrophysiological (Figs. 2-4 ) and intracellular Ca 2ϩ ( Fig. 7) results documented that human inner-wall SC cells respond to subtype-selective A 1 , A 2A , and A 3 adenosine agonists. In the absence of known selective, efficacious agonists of A 2B ARs, we successfully detected evidence for functional A 2B receptors by applying a nonselective agonist (NECA) in the presence of antagonists to the other three receptors. The data are consistent with the functional presence of all four known AR subtypes in inner-wall SC cells. Strategies to stimulate A 1 and A 2B ARs increased, and maneuvers designed to stimulate A 2A ARs decreased, whole cell currents, largely through TEAsensitive channels (Figs. 2-5) . A selective agonist of A 3 ARs stimulated mixed responses.
Together, these results suggest that A 1 and A 2A ARs might modulate aqueous humor outflow at the level of SC cells and that these opposing membrane-transport effects may be involved in the cascade of events leading to the opposing effects of A 1 and A 2A ARs on aqueous humor dynamics. In contrast, we previously observed that selective A 1 , A 2A , and A 3 AR agonists all increased whole cell currents of cultured, nontransformed human TM cells, another potential site of outflow regulation (17) . The observation that A 1 and A 2A AR agonists exert opposite effects on inner-wall SC whole cell currents is analogous to their opposing effects on intraocular pressure. (Fig. 3) . Of the responses to CGS-21680, only the two purely inhibitory effects are averaged here; three additional responses were biphasic, and are included in the data reduction presented in Table 3 .
The mechanisms by which SC cells might mediate the opposing effects of A 1 and A 2A AR agonists on outflow resistance are unclear. Among other possible sequences of events, A 1 AR activation of K ϩ channels is expected to hyperpolarize the SC-cell membrane, increasing the electrical driving force favoring Cl Ϫ release, enhancing transfer of K ϩ and Cl Ϫ and secondarily water to the extracellular space. Cell shrinkage might possibly lower outflow resistance by increasing the probability of transmembrane pore formation (14, 32) or by placing stress on the intercellular tight junctions, reducing the number and complexity of the junctional strands (32, 59) . A 2A AR inhibition of K ϩ channels is expected to exert the opposite effects, which might contribute to cell swelling and enhanced outflow resistance.
Effects of AR Agonists on Ca 2ϩ
Selective A 1 , A 2A , and A 3 AR agonists all increased Ca 2ϩ concentration in inner-wall SC and cannula-derived SC cells (Fig. 7) . Adenosine-selective (P1) receptors also act partly by increasing (A 2A , A 2B ) or decreasing (A 1 , A 3 ) intracellular cAMP levels (18) , but the full signaling cascades are complex and incompletely understood (37) . In view of the similarity of the Ca 2ϩ responses to the different AR agonists, it is uncertain whether their differential outflow effects are mediated by changes in intracellular Ca 2ϩ . Nevertheless, signaling can be conducted in local cellular areas where hormone receptors and downstream pathways and effector channels may be clustered (28, 44, 58) . Thus measurements of changes in second-messenger concentrations averaged over the entire cell may be poor indicators of the changes produced at the cell membrane. For example, increased Ca 2ϩ levels arising from ATP-stimulated apical, but not basolateral, P2Y receptors have been reported to activate Cl Ϫ channels in equine sweat gland E/92/3 cells (58) . Therefore, the increases in total cell Ca 2ϩ measured in the current study may not accurately reflect changes at the target site. In addition, more than additive increases can be produced by co-delivery of adenosine and other biologically active molecules (16) .
Multiple Potential Roles of ARs in Regulating Intraocular Pressure
The present work used adenosine agonists to probe the cellular site of aqueous humor outflow regulation. The data are also relevant to the complex regulation of intraocular pressure by adenosine receptors.
The physiological source of adenosine in the anterior segment in vivo derives from ATP, which can be released by the ciliary epithelium (15, 40) , the site of aqueous humor secretion, and by TM cells in the outflow pathway (17) . ATP is metabolized to adenosine by ecto-enzymes (40) . Adenosine receptors are of particular physiological importance because knockout of A 3 ARs lowers intraocular pressure in mice (5) and antagonists to A 3 ARs lower pressure in both mice (4, 5) and nonhuman primates (45) . The potential pathophysiological importance of ARs is suggested by very recent observations that A 3 ARs are markedly upregulated in nonpigmented ciliary epithelial cells in the pseudoexfoliation syndrome, a major cause of openangle glaucoma (49) . Interestingly, aqueous humor concentrations of adenosine are increased in patients with primary open-angle glaucoma and aqueous adenosine levels are correlated with pressure in ocular hypertensive patients (12) , but whether the changes are a cause of, or response to, the elevated intraocular pressure is unclear.
The current work demonstrates that A 1 and A 2A AR agonists exert opposite effects on whole cell currents in these cells, a difference that might be related to their opposite effects on aqueous humor outflow resistance. The data also suggest that stimulation of A 2B ARs increased SC-cell currents, but the physiological importance of this stimulation is unclear. These receptors are stimulated by adenosine only at concentrations 1-2 orders of magnitude higher than those for activating A 1 , A 2A , or A 3 receptors (Table 2) . In contrast to A 1 and A 2A ARs, A 3 receptors have been thought to increase intraocular pressure by enhancing inflow, an effect mediated by activating Cl Ϫ channels of the nonpigmented cells of the ciliary epithelium (6, 7, 42) . In agreement with this concept, stimulation of A 3 receptors produced no consistent change in SC-cell currents. Taken together with published data, the current results lead us to suggest that A 3 ARs increase intraocular pressure largely by stimulating inflow of aqueous humor and that A 1 , A 2A , and A 2B ARs can modulate pressure by altering outflow resistance at the SC-cell level.
